Janus Henderson Significantly Boosts Stakes in Boeing, TotalEnergies, and Abbott Labs; Trims Argenx

Janus Henderson reported that its Boeing position rose to 3,907,876 shares after buying an additional 1,176,074 shares in the quarter, with Boeing institutional ownership noted at 64.82%.
For TotalEnergies, Janus Henderson disclosed it bought 9,061,622 shares, valuing the stake at about $591.36 million, and said TotalEnergies represented about 0.38% of its portfolio.
Aramark dividend details were provided: Janus Henderson said Aramark declared a quarterly dividend of $0.12 per share, paid June 3 to shareholders of record May 20 (ex-dividend May 20), implying an annualized $0.48 dividend and about a 0.9% yield.
For argenex, Janus Henderson reported it held 2,458,164 shares after selling 117,087 shares, and characterized argenex as its 13th-biggest holding, comprising ~0.9% of its portfolio (about 3.97% of argenex by value).
For Abbott Laboratories, Janus Henderson said it increased its stake to 7,451,542 shares after adding 952,945 shares, with the holding valued at about $933.6 million at period end.
Janus Henderson Group PLC increased its Boeing stake by 43.1%, buying 1,176,074 shares to bring its total to 3,907,876 shares worth roughly $840 million. The move is a bold bet on a company under intense regulatory scrutiny — and signals a broader reshuffling of the firm's blue-chip portfolio.
At the same time, Janus Henderson opened a brand-new $591 million position in TotalEnergies and lifted its Abbott Laboratories stake by nearly 15%. It trimmed its argenex holding by 4.5%, though that position remains its 13th-largest at roughly $2.06 billion.
Boeing has been under fire since a door plug blew out on an Alaska Airlines flight in January 2024, triggering an FAA production freeze. CEO Dave Calhoun announced he would step down, and Boeing's stock fell to multi-year lows. That is exactly when Janus Henderson moved in, according to Ticker Report.
The logic mirrors a playbook used after Boeing's 737 MAX crisis in 2019: institutional investors treat the dip as a buying opportunity. Boeing's institutional ownership now sits at 64.82%. Analysts at Watchlist News describe Janus Henderson's move as a "contrarian signal," suggesting the worst news may already be priced into the stock.
Janus Henderson built an entirely new position in TotalEnergies, buying 9,061,622 shares valued at about $591.36 million. The stake now makes up 0.38% of the firm's portfolio. TotalEnergies has been pushing to attract more North American investors, and has discussed a potential U.S. primary stock listing to close the valuation gap with rivals like ExxonMobil and Chevron.
European oil majors generally trade at lower price-to-earnings ratios than their U.S. peers, and TotalEnergies carries a higher dividend yield. That makes it a "value play," in the language of fund managers — you get more income for less money paid upfront.
Janus Henderson added 952,945 shares of Abbott Laboratories, pushing its total to 7,451,542 shares worth about $933.6 million. Abbott makes products like the FreeStyle Libre glucose monitor and has a stable mix of medical devices and pharmaceuticals. That kind of steady growth makes it a defensive pick — one that holds its value when riskier sectors wobble.
On the selling side, Janus Henderson shed 117,087 shares of argenex, leaving it with 2,458,164 shares. The holding is still worth roughly $2.06 billion and represents about 3.97% of argenex's total value. Analysts frame the trim as routine rebalancing, not a loss of faith in the Belgian biotech's flagship drug, Vyvgart.
Janus Henderson also nudged up its Aramark position to about 18.2 million shares, valued at roughly $671 million. Aramark declared a quarterly dividend of $0.12 per share — paid June 3 to shareholders on record as of May 20. That works out to an annualized $0.48 per share, or a yield of about 0.9%.
With 18.2 million shares, Janus Henderson collects roughly $2.18 million in dividend income each quarter from Aramark alone — about $8.7 million per year. That steady cash flow helps the firm fund higher-risk entries like Boeing without needing to sell other assets.
Publishers
12
Articles
18
Reach
30